ConductScience.org, home

Paper41378286

Long-term outcomes and patterns of failure after empiric SBRT for presumed early-stage lung tumors.

El-Marouk K and 11 others. Front Oncol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Long-term outcomes and patterns of failure after empiric SBRT for presumed early-stage lung tumors. Papers, record 41378286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41378286

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term outcomes and patterns of failure after empiric SBRT for presumed early-stage lung tumors.
PubMed
Journal
Front Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-12-13
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1El-Marouk KKarim
2Degerli EEsra
3Käsmann LLukas
4Kröninger SSophie
5Kauffmann-Guerrero DDiego
6Tufman AAmanda
7Reinmuth NNiels
8Duell TThomas
9Manapov FFarkhad
10Belka CClaus
11Eze CChukwuka
12Mansoorian SSina

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129863955Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.N Engl J Med2018https://conductscience.org/library/papers/29863955PubMed
219097774New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer2009https://conductscience.org/library/papers/19097774PubMed
328461257The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer.J Thorac Oncol2017https://conductscience.org/library/papers/28461257PubMed
417570609Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy.Int J Radiat Oncol Biol Phys2007https://conductscience.org/library/papers/17570609PubMed
530943123Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.J Clin Oncol2019https://conductscience.org/library/papers/30943123PubMed
624334338Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.Ther Adv Respir Dis2014https://conductscience.org/library/papers/24334338PubMed
730225431Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience.Mayo Clin Proc Innov Qual Outcomes2018https://conductscience.org/library/papers/30225431PubMed
839877030Next-Generation Sequencing Analysis on Image-Guided Biopsy Samples in Early-Stage Lung Cancer: Feasibility Study and Comparison With Surgical Samples.JTO Clin Res Rep2025https://conductscience.org/library/papers/39877030PubMed
927987578Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study.Lung Cancer2016https://conductscience.org/library/papers/27987578PubMed
1029658856Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.N Engl J Med2018https://conductscience.org/library/papers/29658856PubMed
1121079145The evolving role of histology in the management of advanced non-small-cell lung cancer.J Clin Oncol2010https://conductscience.org/library/papers/21079145PubMed
1240760181Empiric stereotactic body radiotherapy for presumed early-stage lung cancer : Pulmonary function changes, treatment-related toxicity and survival outcome.Strahlenther Onkol2026https://conductscience.org/library/papers/40760181PubMed
1325981812Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.Lancet Oncol2015https://conductscience.org/library/papers/25981812PubMed
1423649456
Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Chest2013https://conductscience.org/library/papers/23649456PubMed
1519414667Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.J Clin Oncol2009https://conductscience.org/library/papers/19414667PubMed
1632004581To Biopsy or Not to Biopsy?: A Matched Cohort Analysis of Early-Stage Lung Cancer Treated with Stereotactic Radiation with or Without Histologic Confirmation.Int J Radiat Oncol Biol Phys2020https://conductscience.org/library/papers/32004581PubMed
1735108059Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.J Clin Oncol2022https://conductscience.org/library/papers/35108059PubMed
1836890550Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof.Radiat Oncol2023https://conductscience.org/library/papers/36890550PubMed
199129544The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.Arch Intern Med1997https://conductscience.org/library/papers/9129544PubMed
2023287852Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.J Thorac Oncol2013https://conductscience.org/library/papers/23287852PubMed

See all 37 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41378286

GET https://conductscience.org/api/papers/v1/41378286/references?page=2